These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 169313)

  • 21. Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.
    Schmidt NJ; Lennette EH; Magoffin RL
    J Gen Virol; 1969 Apr; 4(3):321-8. PubMed ID: 4306713
    [No Abstract]   [Full Text] [Related]  

  • 22. Newborn infection with Herpesvirus hominis types 1 and 2.
    Nahmias AJ; Dowdle WR; Josey WE; Naib ZM; Painter LM; Luce C
    J Pediatr; 1969 Dec; 75(6):1194-203. PubMed ID: 4187143
    [No Abstract]   [Full Text] [Related]  

  • 23. Resistance of female mice to vaginal infection induced by Herpesvirus hominis type 2: effects of immunization with Mycobacterium bovis, intravenous injection of specific Herpesvirus hominis type 2 antiserum, and a combination of these procedures.
    Baker MB; Larson CL; Ushijima RN; Anderson FD
    Infect Immun; 1974 Dec; 10(6):1230-4. PubMed ID: 4373394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmission of herpesvirus along the trigeminal nerve in rabbits.
    Benda R; Petrovic S; Rychterová V
    Acta Virol; 1972 Nov; 16(6):459-65. PubMed ID: 4404897
    [No Abstract]   [Full Text] [Related]  

  • 25. Reactivity of envelope, capsid, and soluble antigens of Herpesvirus hominis types 1 and 2 in the indirect hemagglutination test.
    Back AF; Schmidt NJ
    Infect Immun; 1974 Jul; 10(1):102-6. PubMed ID: 4366916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of primate herpesvirus antibodies including Herpesvirus simiae by enzyme immunoassay.
    Eichberg JW; Heberling RL; Guajardo JE; Kalter SS
    Dev Biol Stand; 1980; 45():61-6. PubMed ID: 6249690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous Herpesvirus hominis (type 2) infection after renal transplantation.
    Arora KK; Karalakulasingam R; Raff MJ; Martin DG
    JAMA; 1974 Nov; 230(8):1174-5. PubMed ID: 4371291
    [No Abstract]   [Full Text] [Related]  

  • 28. Herpesvirus hominis (simplex) infection with recurrences during infancy.
    Hovig DE; Hodgman JE; Mathies AW; Levan N; Portnoy B
    Am J Dis Child; 1968 Apr; 115(4):438-44. PubMed ID: 4296013
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibody to Herpesvirus hominis types 1 and 2 in patients with Hodgkin's disease and carcinoma of the nasopharynx.
    Catalano LW; Goldman JM
    Cancer; 1972 Mar; 29(3):597-602. PubMed ID: 4334236
    [No Abstract]   [Full Text] [Related]  

  • 30. Latency of Herpes Simiae (B virus) in rabbits.
    Vizoso AD
    Br J Exp Pathol; 1975 Dec; 56(6):489-94. PubMed ID: 177039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute respiratory disease of university students with special reference to the etiologic role of Herpesvirus hominis.
    Glezen WP; Fernald GW; Lohr JA
    Am J Epidemiol; 1975 Feb; 101(2):111-21. PubMed ID: 164768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology of varicella-zoster-virus and of herpesvirus hominis (author's transl)].
    Falke D
    Immun Infekt; 1974 Oct; 2(4):183-8. PubMed ID: 4377569
    [No Abstract]   [Full Text] [Related]  

  • 33. Techniques for typing Herpesvirus hominis antibody: a comparison of inhibition of peroxidase-labelled antibody staining with inhibition of indirect haemagglutination and with microneutralisation.
    Gerna G; Chambers RW
    J Med Microbiol; 1977 Aug; 10(3):309-16. PubMed ID: 197239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to Herpesvirus hominis types 1 and 2 in malnourished Nigerian children.
    Johnson AO; Salimonu LS; Osunkoya BO
    Arch Dis Child; 1981 Jan; 56(1):45-8. PubMed ID: 6258486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpesvirus hominis type 2 infections in rabbits: effect of prior immunization with attenuated Mycobacterium bovis (BCG) cells.
    Larson CL; Ushijima RN; Karim R; Baker MB; Baker RE
    Infect Immun; 1972 Oct; 6(4):465-8. PubMed ID: 4344024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Method for the preparation of a herpesvirus hominis fluorescent conjugate for direct immunofluorescence.
    Marks MI
    Arch Gesamte Virusforsch; 1970; 32(4):373-8. PubMed ID: 4322850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of the virus isolation and immunofluorescent staining methods in diagnosis of infections with herpes simplex virus.
    Cho CT; Feng KK
    J Infect Dis; 1978 Oct; 138(4):536-40. PubMed ID: 213499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic and biologic differences in herpesvirus hominis.
    Nahmias AJ; Dowdle WR
    Prog Med Virol; 1968; 10():110-59. PubMed ID: 4304588
    [No Abstract]   [Full Text] [Related]  

  • 39. [Herpesvirus hominis type 2 and Epstein-Barr virus antibodies in patients with cancer of the uterine cervix].
    Vestergaard BF; Hornsleth A; Pedersen SN
    Ugeskr Laeger; 1973 Jul; 135(27):1425-8. PubMed ID: 4357007
    [No Abstract]   [Full Text] [Related]  

  • 40. Typing of Herpesvirus hominis strains by indirect immunofluorescence and biological markers.
    Leinikki P
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Feb; 81(1):65-9. PubMed ID: 4353970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.